VTRO (Vitro Biopharma) OCF Margin %: -67.32% (As of Oct. 2022)


What is Vitro Biopharma OCF Margin %?

Vitro Biopharma VTRO OCF Margin % is -67.32% as of Oct. 2022. The stock has 6 warning signs investors should review.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Vitro Biopharma's Cash Flow from Operations for the three months ended in Oct. 2022 was $-2.22 Mil. Vitro Biopharma's Revenue for the three months ended in Oct. 2022 was $3.29 Mil. Therefore, Vitro Biopharma's OCF Margin % for the quarter that ended in Oct. 2022 was -67.32%.

As of today, Vitro Biopharma's current OCF Yield % is 0.00%.

The historical rank and industry rank for Vitro Biopharma's OCF Margin % or its related term are showing as below:


VTRO's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Vitro Biopharma OCF Margin % Related Terms

Vitro Biopharma OCF Margin % Historical Data

* Premium members only.

The historical data trend for Vitro Biopharma's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitro Biopharma OCF Margin % Chart

Vitro Biopharma Annual Data
Trend Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -83.92 -101.01 0.00 -76.13 -67.32

Vitro Biopharma Quarterly Data
Oct00 Oct01 Oct02 Oct03 Oct04 Oct05 Oct06 Oct07 Oct08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -83.92 -101.01 0.00 -76.13 -67.32

Vitro Biopharma OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Vitro Biopharma's OCF Margin for the fiscal year that ended in Oct. 2022 is calculated as

OCF Margin=Cash Flow from Operations (A: Oct. 2022 )/Revenue (A: Oct. 2022 )
=-2.217/3.293
=-67.32 %

Vitro Biopharma's OCF Margin for the quarter that ended in Oct. 2022 is calculated as

OCF Margin=Cash Flow from Operations (Q: Oct. 2022 )/Revenue (Q: Oct. 2022 )
=-2.217/3.293
=-67.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -67.32% mean?
Vitro Biopharma (VTRO) has a OCF Margin % of -67.32% as of Oct. 2022. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vitro Biopharma and its competitors.
Is Vitro Biopharma's OCF Margin % too high?
Vitro Biopharma's current OCF Margin % is -67.32%.
How does Vitro Biopharma's OCF Margin % compare to ?
Vitro Biopharma's OCF Margin % of -67.32% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vitro Biopharma and its competitors. Vitro Biopharma's current OCF Margin % is -67.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitro Biopharma stock overvalued right now?
Vitro Biopharma (VTRO) has a current OCF Margin % of -67.32%. The current OCF Margin % is -67.32%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Vitro Biopharma (VTRO), the current OCF Margin % is -67.32% as of Oct. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitro Biopharma Business Description

Comparable Companies
Address 4621 Technology Drive, Golden, CO, USA, 80403
Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.